World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
24573
World Ranking
1880
National Ranking
16

Overview

Finn Sellebjerg is affiliated with Copenhagen University Hospital in Denmark and has contributed extensively to the field of medicine, with a particular focus on multiple sclerosis and related neurological disorders. Their research spans pathology, neurology, immunology, oncology, and rheumatology.

The scientist's recent papers cover significant topics in multiple sclerosis, including disease progression, treatment strategies, and biomarkers. Notable publications include:

  • Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis, 2021, JAMA Neurology
  • Locus for severity implicates CNS resilience in progression of multiple sclerosis, 2023, Nature
  • Initial high-efficacy disease-modifying therapy in multiple sclerosis, 2020, Neurology
  • Serum neurofilament light as a biomarker in progressive multiple sclerosis, 2020, Neurology
  • The gut microbiota in multiple sclerosis varies with disease activity, 2023, Genome Medicine

Frequent co-authors collaborating with Sellebjerg include:

  • Melinda Magyari
  • Jeppe Romme Christensen
  • Helle Bach Søndergaard
  • Xavier Montalbán
  • Per Soelberg Sørensen

Sellebjerg's work has been published primarily in journals such as:

  • Multiple Sclerosis and Related Disorders
  • Neurology
  • Multiple Sclerosis Journal
  • Frontiers in Immunology
  • Neurology Neuroimmunology & Neuroinflammation

Their research fields emphasize medicine with a strong focus on subfields including pathology and forensic medicine, neurology, immunology, oncology, and rheumatology. This multidisciplinary approach supports investigations into complex neurological and immune-related diseases.

Main research topics covered in Sellebjerg's body of work are:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Immunotherapy and Immune Responses
  • Polyomavirus and related diseases
  • T-cell and B-cell Immunology
  • Systemic Lupus Erythematosus Research
  • Rheumatoid Arthritis Research and Therapies

Best Publications

  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

    Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer

  • Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

    Unknown

  • Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

    Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis

  • Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

    Torben L. Sørensen;Marie Tani;Jakob Jensen;Virginia Pierce

  • Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course

    Mohsen Khademi;Ingrid Kockum;Magnus L Andersson;Ellen Iacobaeus

  • Multiple sclerosis: A study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system

    Torben L. Sørensen;Corinna Trebst;Pia Kivisäkk;Karen L. Klaege

  • CCR1+/CCR5+ Mononuclear Phagocytes Accumulate in the Central Nervous System of Patients with Multiple Sclerosis

    Corinna Trebst;Torben Lykke Sørensen;Pia Kivisäkk;Martha K. Cathcart

  • Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression

    Jeppe Romme Christensen;Lars Börnsen;Rikke Ratzer;Fredrik Piehl

  • Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS

    F. Sellebjerg;L. Börnsen;M. Khademi;M. Krakauer

  • T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis.

    Chris J Hedegaard;Martin Krakauer;Klaus Bendtzen;Henrik Lund

  • CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis

    Finn Sellebjerg;Hans O Madsen;Claus V Jensen;Jakob Jensen

  • FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS

    Yawei Liu;Robert Carlsson;Manuel Comabella;Jun Yang Wang

  • Differential microRNA expression in blood in multiple sclerosis

    Helle Bach Søndergaard;Dan Hesse;Martin Krakauer;Per Soelberg Sørensen

  • Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls

    Sergio E. Baranzini;Pouya Khankhanian;Nikolaos A. Patsopoulos;Michael Li

  • A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis

    H G Roed;A Langkilde;F Sellebjerg;M Lauritzen

  • Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients

    Per Soelberg Sorensen;Nils Koch-Henriksen;Nils Koch-Henriksen;Thor Petersen;Mads Ravnborg

  • Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis

    T. L. Sørensen;F. Sellebjerg;C. V. Jensen;R. M. Strieter

  • Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system

    F. Sellebjerg;T.L. Sørensen

  • Natalizumab in progressive MS Results of an open-label, phase 2A, proof-of-concept trial

    Jeppe Romme Christensen;Rikke Ratzer;Lars Börnsen;Mark Lyksborg

  • Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis.

    Marina R von Essen;Cecilie Ammitzbøll;Rikke H Hansen;Eva R S Petersen

  • The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers

    M. Khademi;L. Bornsen;F. Rafatnia;M. Andersson

  • Absence of MxA induction by interferon β in patients with MS reflects complete loss of bioactivity

    D. Hesse;F. Sellebjerg;P. Soelberg Sorensen

  • IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS.

    P. Soelberg Sorensen;J. Haas;F. Sellebjerg;T. Olsson

Frequent Co-Authors

Per Soelberg Sørensen
Per Soelberg Sørensen University of Copenhagen
Hanne F. Harbo
Hanne F. Harbo Oslo University Hospital
Ingrid Kockum
Ingrid Kockum Karolinska Institute
Jan Hillert
Jan Hillert Karolinska Institute
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Michael Christiansen
Michael Christiansen Statens Serum Institut
Manuel Comabella
Manuel Comabella Vall d'Hebron Institut de Recerca
Tomas Olsson
Tomas Olsson Karolinska Institute
Kjell-Morten Myhr
Kjell-Morten Myhr University of Bergen
Fredrik Piehl
Fredrik Piehl Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can open diverse career opportunities. Nursing degrees, for example, provide a strong foundation in patient care and biological sciences, closely linked to immunological principles. Students looking to enter nursing quickly might consider accelerated nursing programs, which offer a faster route to obtaining a Bachelor of Science in Nursing (BSN).

Entry into nursing is also accessible through LPN pathways. Those seeking easier admission can explore easy admission LPN programs, which provide essential skills for patient care and serve as stepping stones to advanced nursing roles.

Advanced practice nurses, such as Nurse Practitioners (NPs), often work closely with immunologists in clinical environments. Prospective students might find guidance by looking into what is the easiest NP program to identify programs suited to their needs and timelines.

Specializations like Psychiatric Mental Health Nurse Practitioner (PMHNP) combine mental health with immunological considerations. For those interested, selecting programs with strong clinical support is crucial; the best PMHNP programs offer excellent clinical placement rates to enhance hands-on learning.

Best Scientists Citing Finn Sellebjerg

Trending Scientists